See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

Novo Nordisk Hits Record High After Study Finds Obesity Drug Wegovy Cuts Heart Risk

Posted on AllSides August 8th, 2023
From The Right

Novo Nordisk Hits Record High After Study Finds Obesity Drug Wegovy Cuts Heart Risk Novo Nordisk shares in Copenhagen jumped to a record high on Tuesday after headline results from the SELECT cardiovascular outcomes trial showed obesity drug Wegovy reduces cardiovascular events and helps with weight loss. "The double-blinded trial compared subcutaneous once-weekly semaglutide 2.4 mg with placebo as an adjunct to standard of care for prevention of major adverse cardiovascular events (MACEs) over a period of up to five years," Novo Nordisk wrote in a statement. The statement continued,...

Read full story
https://zerohedge.com/markets/novo-nordisk-hits-record-high-after-obesity-drug-wegovy-cuts-heart-risk

More News about Banking and Finance from the Left, Center and Right

From the Left

From the Center

From the Right